Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-24T04:08:50.875Z Has data issue: false hasContentIssue false
  • English
  • Français

Platelet monoamine oxidase activity in obsessive-compulsive disorder

Published online by Cambridge University Press:  16 April 2020

Manuel Arrojo ,
Enrique Baca-Garcia ,
Maria Mercedes Perez-Rodriguez ,
Helen Dolengevich-Segal ,
Mercedes Navio-Acosta ,
Beatriz Rodriguez-Salgado  and
Jeronimo Saiz-Ruiz
Manuel Arrojo
Affiliation:
Department of Psychiatry, Ramon y Cajal Hospital, Carretera de Colmenar Viejo km 9.1, 28034Madrid, Spain
Enrique Baca-Garcia*
Affiliation:
Department of Neurosciences, Columbia University Medical Center, 1051 Riverside Drive, Suite 2917/Unit 42, New York, NY10032, USA Department of Psychiatry, Fundacion Jimenez Diaz, Avenida Reyes Catolicos 2, 28040Madrid, Spain Department of Psychiatry, Faculty of Medicine, Autonoma University of Madrid, Calle Arzobispo Morcillo, 28029Madrid, Spain
Maria Mercedes Perez-Rodriguez
Affiliation:
Department of Psychiatry, Ramon y Cajal Hospital, Carretera de Colmenar Viejo km 9.1, 28034Madrid, Spain
Helen Dolengevich-Segal
Affiliation:
Department of Psychiatry, Ramon y Cajal Hospital, Carretera de Colmenar Viejo km 9.1, 28034Madrid, Spain
Mercedes Navio-Acosta
Affiliation:
Department of Psychiatry, Ramon y Cajal Hospital, Carretera de Colmenar Viejo km 9.1, 28034Madrid, Spain
Beatriz Rodriguez-Salgado
Affiliation:
Department of Psychiatry, Ramon y Cajal Hospital, Carretera de Colmenar Viejo km 9.1, 28034Madrid, Spain
Jeronimo Saiz-Ruiz
Affiliation:
Department of Psychiatry, Ramon y Cajal Hospital, Carretera de Colmenar Viejo km 9.1, 28034Madrid, Spain University of Alcala, Madrid, Spain
*
*Corresponding author. Department of Neurosciences, Columbia University Medical Center, 1051 Riverside Drive, Suite 2917/Unit 42, New York, NY 10032, USA. Tel.: +1 212 543 6544; fax: +1 212 543 6017. E-mail addresses: marrojo3@hotmail.com (M. Arrojo), ebacgar2@yahoo.es (E. Baca-Garcia), merperez@yahoo.com (M.M. Perez-Rodriguez), edolen@ya.com (H. Dolengevich-Segal), mercedes.navio@hrc.es (M. Navio-Acosta), beatriz.rodriguez@hrc.es (B. Rodriguez-Salgado), jsaiz.hrc@ salud.madrid.org (J. Saiz-Ruiz).
Get access

Abstract

Response to SSRIs suggests the implication of the serotonergic system in obsessive-compulsive disorder (OCD). However, biological studies on serotonergic function in OCD have yielded contradictory results. Platelet monoamine oxidase (MAO) activity has been proposed as an index of cerebral serotonin activity.

The aim of this study was to examine platelet MAO activity in 29 OCD patients and 29 healthy controls matched by age, sex and tobacco use. We also explored the relationship between platelet MAO activity and aggressive obsessions in OCD patients.

There were no differences in platelet MAO activity between OCD patients and healthy controls. We found a significant correlation between platelet MAO activity and Y-BOCS scores in the group of patients with Y-BOCS scores >15.

OCD patients with aggressive obsessions had significantly lower levels of platelet MAO activity than patients without aggressive obsessions.

Our results suggest that platelet MAO activity may be a marker of OCD severity, and that low platelet MAO activity may be associated with aggressive obsessions in OCD patients.

Keywords

Obsessive-compulsive disorderPlatelet MAO activitySerotoninAggression
Type
Original article
Information
European Psychiatry , Volume 22 , Issue 8 , November 2007 , pp. 525 - 529
Copyright
Copyright © Elsevier Masson SAS 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

1

Tel./fax: +34 91 336 83 93.

References

Anthenelli, R.M., Smith, T.L., Craig, C.E., Tabakoff, B., Schuckit, M.A.Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates. Biol Psychiatry 1995;38:361–368.CrossRefGoogle ScholarPubMed
Baca-Garcia, E., Salgado, B.R., Segal, H.D., Lorenzo, C.V., Acosta, M.N., Romero, M.A.et al.A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism. Prog Neuropsychopharmacol Biol Psychiatry Jun 2005;29(5):713–717.CrossRefGoogle ScholarPubMed
Baca-Garcia, E., Vaquero-Lorenzo, C., Diaz-Hernandez, M., Rodriguez-Salgado, B., Dolengevich-Segal, H., Arrojo-Romero, M.et al.Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog Neuropsychopharmacol Biol Psychiatry 2007 Mar 30; 31(2):416–420.CrossRefGoogle Scholar
Blanco, C., Orensanz-Munoz, L., Blanco-Jerez, C., Saiz-Ruiz, J.Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996;153:119–121.Google ScholarPubMed
Carrasco, J.L., Diaz-Marsa, M., Hollander, E., Cesar, J., Saiz-Ruiz, J.Decreased platelet monoamine oxidase activity in female bulimia nervosa. Eur Neuropsychopharmacol 2000;10:113–117.CrossRefGoogle ScholarPubMed
Cath, D.C., Spinhoven, P., Landman, A.D., Van Kempen, G.M.Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder. J Psychopharmacol 2001;15:111–119.CrossRefGoogle ScholarPubMed
Charney, D.S., Goodman, W.K., Price, L.H., Woods, S.W., Rasmussen, S.A., Heninger, G.R.Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 1988;45:177–185.CrossRefGoogle ScholarPubMed
Conde, V., Franch, J.I.Escalas de evaluación comportamental para la cuantificación de la sintomatología de los trastornos angustiosos y depresivos. Madrid: Upjohn; 1984.Google Scholar
Denys, D., de Geus, F., van Megen, H.J., Westenberg, H.G.Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res 2004;128:273–280.CrossRefGoogle ScholarPubMed
Flament, M.F., Rapoport, J.L., Murphy, D.L., Berg, C.J., Lake, C.R.Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry 1987;44:219–225.CrossRefGoogle ScholarPubMed
Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischmann, R.L., Hill, C.L.et al.The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006–1011.CrossRefGoogle ScholarPubMed
Hewlett, W.A., Vinogradov, S., Martin, K., Berman, S., Csernansky, J.G.Fenfluramine stimulation of prolactin in obsessive-compulsive disorder. Psychiatry Res 1992;42(1):81–92.CrossRefGoogle ScholarPubMed
Hollander, E., DeCaria, C.M., Nitescu, A., Gully, R., Suckow, R.F., Cooper, T.B.et al.Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 1992;49:21–28.CrossRefGoogle ScholarPubMed
Hollander, E., Fay, M., Cohen, B.Serotoninergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioural findings. Am J Psychiatry 1988;145:1015–1017.Google Scholar
Insel, T.R., Mueller, E.A., Alterman, I., Linnoila, M., Murphy, D.L.Obsessive-compulsive disorder and serotonin: is there a connection?. Biol Psychiatry 1985;20:1174–1188.CrossRefGoogle ScholarPubMed
Kaneda, Y., Fujii, A., Nagamine, I.Platelet serotonin concentrations in medicated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:983–992.CrossRefGoogle ScholarPubMed
Karno, M., Golding, J.M., Sorenson, S.B., Burnam, M.A.The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094–1099.CrossRefGoogle ScholarPubMed
Meltzer, H.Y., Zureick, J.L.Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions. Psychiatry Res 1987;22:99–109.CrossRefGoogle ScholarPubMed
Muck-Seler, D., Pivac, N., Sagud, M., Jakovljevic, M., Mihaljevic-Peles, A.The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:1235–1243.CrossRefGoogle ScholarPubMed
Murphy, D.L., Wyatt, R.J.Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature 1972;238:225–226.CrossRefGoogle ScholarPubMed
Pivac, N., Muck-Seler, D., Sagud, M., Jakovljevic, M., Mustapic, M., Mihaljevic-Peles, A.Long-term sertraline treatment and peripheral biochemical markers in female depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:759–765.CrossRefGoogle ScholarPubMed
Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E.et al.Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22–23.Google ScholarPubMed
Skondras, M., Markianos, M., Botsis, A., Bistolaki, E., Christodoulou, G.Platelet monoamine oxidase activity and psychometric correlates in male violent offenders imprisoned for homicide or other violent acts. Eur Arch Psychiatry Clin Neurosci 2004;254(6):380–386.CrossRefGoogle ScholarPubMed
Stahl, S.M. In: Longenecker, G.S. editor. The platelets physiology and pharmacology. Platelets as pharmacological models for the receptors and biochemistry of monoaminergic neurons, vol. 307 Orlando: Academic; p. 340.Google Scholar
Stalenheim, E.G.Long-term validity of biological markers of psychopathy and criminal recidivism: follow-up 6–8 years after forensic psychiatric investigation. Psychiatry Res 2004;121(3):1985. p. 281–291.CrossRefGoogle ScholarPubMed
Sullivan, J.L., Baenziger, J.C., Wagner, D.L., Rauscher, F.P., Nurnberger, J.I. Jr., Holmes, J.S.Platelet MAO in subtypes of alcoholism. Biol Psychiatry 1990;27:911–922.CrossRefGoogle ScholarPubMed
Thoren, P., Asberg, M., Cronholm, B., Jornestedt, L., Traskman, L.Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry 1980;37:1281–1285.CrossRefGoogle ScholarPubMed
Verkes, R.J., Pijl, H., Meinders, A.E., Van Kempen, G.M.Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior. Biol Psychiatry 1996;40:173–180.CrossRefGoogle ScholarPubMed
Weizman, A., Carmi, M., Hermesh, H., Shahar, A., Apter, A., Tyano, S.et al.High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 1986;143:335–339.Google ScholarPubMed
Zohar, J., Mueller, E.A., Insel, T.R., Zohar-Kadouch, R.C., Murphy, D.L.Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 1987;44:946–951.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.